Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
A/Victoria/2570/2019 (H1N1);;B/Washington/02/2019 (B/Victoria lineage);;B/Phuket/3073/2013 (B/Yamagata lineage);;A/Hong Kong/2671/2019 (H3N2)
高端疫苗生物製劑股份有限公司 新竹縣竹北市生醫三路68號 (53943057)
J07BB02
無菌懸浮注射液
A/Victoria/2570/2019 (H1N1) (8012002530) MCG; B/Phuket/3073/2013 (B/Yamagata lineage) (8012006241) MCG; B/Washington/02/2019 (B/Victoria lineage) (8012006831) MCG; A/Hong Kong/2671/2019 (H3N2) (8012017060) MCG
包裝
菌 疫
須由醫師處方使用
GC Biopharma Corporation, HWASUN PLANT 40 Sandan-gil, Hwasun-eup, Hwasun-gun, Jeollanam-do, Republic of Korea KR
influenza, inactivated, split virus or surface antigen
適用於3歲以上兒童及成人之主動免疫接種,藉以預防此疫苗所涵蓋之兩種A型流感病毒及兩種B型流感病毒所引起的流行性感冒。
有效日期: 2028/03/13; 英文品名: MVC FLU Quadrivalent pre-filled syringe injection
2023-03-13